ChemicalBook > Product Catalog >API >Circulatory system drugs >Peripheral vasodilators >Praliciguat

Praliciguat

Praliciguat Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: BioPharmaMatrix,Inc.  
Tel: 0510-86010668 13395169561;
Email: sales@biopharmamatrix.com
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Company Name: Shanghai SuperLan Chemcial Technique Centre  
Tel: 0-2022843681 15618226720
Email: chaolaichem@foxmail.com

Praliciguat manufacturers

  • Praliciguat
  • Praliciguat pictures
  • $153.00
  • 2026-07-17
  • CAS:1628730-49-3
  • Purity: 99.05%
  • Supply Ability: 10g
Praliciguat Basic information
Product Name:Praliciguat
Synonyms:Praliciguat;IW-1973;2-Propanol, 1,1,1,3,3,3-hexafluoro-2-[[[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(3-isoxazolyl)-1H-pyrazol-3-yl]-4-pyrimidinyl]amino]methyl]-;Praliciguat,IW 1973,Guanylate Cyclase,Inhibitor,IW1973,inhibit;Praliciguat, 10 mM in DMSO
CAS:1628730-49-3
MF:C21H14F8N6O2
MW:534.36
EINECS:
Product Categories:
Mol File:1628730-49-3.mol
Praliciguat Structure
Praliciguat Chemical Properties
Boiling point 588.5±50.0 °C(Predicted)
density 1.60±0.1 g/cm3(Predicted)
solubility DMSO : 250 mg/mL (467.85 mM; Need ultrasonic)
pka8.99±0.29(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
Praliciguat Usage And Synthesis
UsesPraliciguat (IW-1973) is a potent and orally active soluble guanylate cyclase stimulator, enhances NO signaling, acts as a vasodilator. Praliciguat (IW-1973) stimulates sGC in HEK-293 cells with an EC50 of 197 nM[1].
DefinitionChEBI: Praliciguat is a member of the class of pyrazoles that is 5-fluoro-2-(1H-pyrazol-3-yl)pyrimidine which is substituted by a 2-fluorobenzyl group at position 1, 1,2-oxazol-3-yl group at position 5, and by a [3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propyl]nitrilo group at position 4. It is a soluble guanylate cyclase stimulator under clinical development for the treatment of heart failure with preserved ejection fraction. It has a role as a soluble guanylate cyclase activator, an anti-inflammatory agent, a vasodilator agent and an antihypertensive agent. It is a member of isoxazoles, a member of pyrazoles, an organofluorine compound, an aminopyrimidine, a tertiary alcohol, a secondary amino compound and a member of monofluorobenzenes.
References[1] Daniel P Zimmer, et al. Abstract 16938: IW-1973 is a Potent Soluble Guanylate Cyclase Stimulator in vitro and in vivo With Extensive Tissue Distribution.
Praliciguat Preparation Products And Raw materials
Tag:Praliciguat(1628730-49-3) Related Product Information
Olinciguat Praliciguat Doxorubicin hydrochloride Ruxolitinib 2-Deoxy-D-glucose MonoMethyl auristatin E